Company at a Glance
Price
Infographic
Overview
Sanofi is a leading global pharmaceutical company headquartered in Paris, France. It was founded in 1973 and has a presence in over 170 countries. The company specializes in developing and manufacturing a wide range of prescription drugs and consumer healthcare products.
Sanofi's mission is to provide high-quality, innovative healthcare solutions to improve the lives of people around the world. They focus on four main therapeutic areas: diabetes, cardiovascular diseases, vaccines, and general medicines.
The company has a diverse portfolio of products, including blockbuster drugs such as Lantus (insulin), Plavix (antiplatelet), and Dupixent (eczema treatment). They also have a strong presence in consumer healthcare with popular brands like Allegra, Dulcolax, and Gold Bond.
In addition to their pharmaceutical and consumer healthcare businesses, Sanofi also has a strong commitment to research and development. They have partnerships and collaborations with universities, research institutions, and biotech companies to discover and develop new treatments for a variety of diseases.
Sanofi is committed to sustainability and social responsibility and has several initiatives in place to reduce their environmental impact and give back to the communities where they operate. These include programs for access to medicines in developing countries, environmental protection, and employee volunteer projects.
Overall, Sanofi is a global healthcare company dedicated to improving the lives of people through innovative and high-quality healthcare solutions.
How to explain to a 10 year old kid about the company?
π Want to read more about Sanofi?
Sign up for free
or
log in
π Donβt miss "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!
U2Fub2ZpIG lzIGEgY29t cGFueSB0aG F0IGhlbHBz IHBlb3BsZS BzdGF5IGhl YWx0aHkgYW 5kIGZlZWwg YmV0dGVyIH doZW4gdGhl eSBhcmUgc2 ljay4gVGhl eSBtYWtlIH RoaW5ncyBs aWtlIG1lZG ljaW5lIGFu ZCB2YWNjaW 5lcy4gTWVk aWNpbmUgaG VscHMgcGVv cGxlIGdldC BiZXR0ZXIg ZnJvbSBpbG xuZXNzZXMs IGFuZCB2YW NjaW5lcyBo ZWxwIHByb3 RlY3QgcGVv cGxlIGZyb2 0gZ2V0dGlu ZyBzaWNrIG luIHRoZSBm aXJzdCBwbG FjZS48YnI+ SGVyZeKAmX MgaG93IFNh bm9maSBtYW tlcyBtb25l eTogV2hlbi B0aGV5IGNy ZWF0ZSBuZX cgbWVkaWNp bmVzIGFuZC B2YWNjaW5l cyB0aGF0IH dvcmsgd2Vs bCwgZG9jdG 9ycyBjYW4g cHJlc2NyaW JlIHRoZW0g dG8gcGF0aW VudHMsIGFu ZCBob3NwaX RhbHMgY2Fu IHVzZSB0aG VtIHRvIGhl bHAgc2ljay BwZW9wbGUu IFdoZW4gdG hlc2UgbWVk aWNpbmVzIG FyZSBzb2xk LCBTYW5vZm kgZWFybnMg bW9uZXkuIF RoZXkgYWxz byBtYWtlIG 1vbmV5IGJ5 IHNlbGxpbm cgdGhlaXIg cHJvZHVjdH MgaW4gZGlm ZmVyZW50IG NvdW50cmll cyBhcm91bm QgdGhlIHdv cmxkLCBub3 QganVzdCBp biBvbmUgcG xhY2UuPGJy PlNhbm9maS BpcyBzdWNj ZXNzZnVsIG ZvciBhIGZl dyByZWFzb2 5zLiBGaXJz dCwgdGhleS BoYXZlIGEg bG90IG9mIH NjaWVudGlz dHMgYW5kIH Jlc2VhcmNo ZXJzIHdoby B3b3JrIGhh cmQgdG8gZG lzY292ZXIg bmV3IGFuZC BiZXR0ZXIg bWVkaWNpbm VzLiBUaGV5 IHNwZW5kIG EgbG90IG9m IHRpbWUgYW 5kIG1vbmV5 IHRlc3Rpbm cgdGhlc2Ug bWVkaWNpbm VzIHRvIG1h a2Ugc3VyZS B0aGV5IGFy ZSBzYWZlIG FuZCBlZmZl Y3RpdmUuIF NlY29uZCwg dGhlcmUgYX JlIGFsd2F5 cyBuZXcgaG VhbHRoIGNo YWxsZW5nZX MgYW5kIGRp c2Vhc2VzLC BzbyBwZW9w bGUgd2lsbC BhbHdheXMg bmVlZCBtZW RpY2luZSBh bmQgdmFjY2 luZXMsIHdo aWNoIG1lYW 5zIHRoZXJl IGlzIGEgY2 9uc3RhbnQg ZGVtYW5kIG ZvciB3aGF0 IHRoZXkgY3 JlYXRlLiBM YXN0bHksIH RoZXkgYWxz byB3b3JrIH dpdGggb3Ro ZXIgb3JnYW 5pemF0aW9u cyBhbmQgZ2 92ZXJubWVu dHMgdG8gaG VscCBzcHJl YWQgdGhlaX IgcHJvZHVj dHMgYXJvdW 5kIHRoZSB3 b3JsZC48Yn I+SW4gdGhl IGZ1dHVyZS wgU2Fub2Zp IGlzIGxpa2 VseSB0byBz dGF5IHN1Y2 Nlc3NmdWwg YmVjYXVzZS B0aGV5IGtl ZXAgZGlzY2 92ZXJpbmcg bmV3IHRyZW F0bWVudHMs IGFuZCBhcy Btb3JlIHBl b3BsZSBhcm 91bmQgdGhl IHdvcmxkIG 5lZWQgaGVs cCB3aXRoIG hlYWx0aCBw cm9ibGVtcy wgdGhleSB3 aWxsIGNvbn RpbnVlIHRv IGJlIGltcG 9ydGFudC4g UGx1cywgdG hleSBhcmUg d29ya2luZy BvbiBuZXcg dHlwZXMgb2 YgbWVkaWNp bmVzLCBsaW tlIHRob3Nl IHRoYXQgaG VscCB3aXRo IGxvbmctbG FzdGluZyBk aXNlYXNlcy wgd2hpY2gg bWVhbnMgdG hleSB3aWxs IGFsd2F5cy BoYXZlIHNv bWV0aGluZy B0byBvZmZl ciB0byBoZW xwIG1hbnkg cGVvcGxlLj xicj4=
What is special about the company?
π Want to read more about Sanofi?
Sign up for free
or
log in
π Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting
VGhlcmUgYX JlIHNldmVy YWwgdGhpbm dzIHRoYXQg bWF5IGJlIG NvbnNpZGVy ZWQgc3BlY2 lhbCBhYm91 dCB0aGUgU2 Fub2ZpIGNv bXBhbnk6PG JyPjEuIEds b2JhbCBwcm VzZW5jZTog U2Fub2ZpIG lzIGEgbXVs dGluYXRpb2 5hbCBwaGFy bWFjZXV0aW NhbCBjb21w YW55IHdpdG ggYSBnbG9i YWwgcHJlc2 VuY2UgaW4g b3ZlciAxNz AgY291bnRy aWVzLiBUaG lzIGFsbG93 cyB0aGVtIH RvIHJlYWNo IGEgZGl2ZX JzZSByYW5n ZSBvZiBwYX RpZW50cyBh bmQgc2Vydm UgZGl2ZXJz ZSBtZWRpY2 FsIG5lZWRz IGFyb3VuZC B0aGUgd29y bGQuPGJyPj IuIERpdmVy c2lmaWVkIH BvcnRmb2xp bzogU2Fub2 ZpIGhhcyBh IHdlbGwtZG l2ZXJzaWZp ZWQgcG9ydG ZvbGlvLCB3 aXRoIGEgZm 9jdXMgb24g bXVsdGlwbG UgdGhlcmFw ZXV0aWMgYX JlYXMgaW5j bHVkaW5nIG NhcmRpb3Zh c2N1bGFyIG Rpc2Vhc2Vz LCBkaWFiZX Rlcywgb25j b2xvZ3ksIG ltbXVub2xv Z3ksIGFuZC ByYXJlIGRp c2Vhc2VzLi BUaGlzIGhl bHBzIHRoZS Bjb21wYW55 IHdpdGhzdG FuZCB0aGUg aW1wYWN0IG 9mIHNoaWZ0 cyBpbiBtYX JrZXQgZGVt YW5kIGZvci BwYXJ0aWN1 bGFyIGRydW dzLjxicj4z LiBJbm5vdm F0aW9uIGFu ZCByZXNlYX JjaDogU2Fu b2ZpIGlzIG NvbW1pdHRl ZCB0byByZX NlYXJjaCBh bmQgaW5ub3 ZhdGlvbiwg aW52ZXN0aW 5nIGhlYXZp bHkgaW4gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 IChSJkQpIH RvIGJyaW5n IGxpZmUtc2 F2aW5nIGFu ZCBsaWZlLW VuaGFuY2lu ZyBtZWRpY2 luZXMgdG8g cGF0aWVudH MuIEluIDIw MTksIHRoZS Bjb21wYW55 IGludmVzdG VkIG92ZXIg NiBiaWxsaW 9uIGV1cm9z IGluIFImRC 48YnI+NC4g UGF0aWVudC 1jZW50cmlj IGFwcHJvYW NoOiBTYW5v ZmkgcGxhY2 VzIGEgc3Ry b25nIGVtcG hhc2lzIG9u IHVuZGVyc3 RhbmRpbmcg YW5kIGFkZH Jlc3Npbmcg dGhlIG5lZW RzIG9mIHBh dGllbnRzLi BUaGUgY29t cGFueSB1c2 VzIGEgcGF0 aWVudC1jZW 50cmljIGFw cHJvYWNoIG luIGRldmVs b3Bpbmcgbm V3IGRydWdz IGFuZCBpbX Byb3Zpbmcg ZXhpc3Rpbm cgdHJlYXRt ZW50cy48Yn I+NS4gQ29y cG9yYXRlIH NvY2lhbCBy ZXNwb25zaW JpbGl0eTog U2Fub2ZpIG lzIGNvbW1p dHRlZCB0by Bjb3Jwb3Jh dGUgc29jaW FsIHJlc3Bv bnNpYmlsaX R5IGluaXRp YXRpdmVzLC BpbmNsdWRp bmcgcHJvdm lkaW5nIGFj Y2VzcyB0by BtZWRpY2lu ZXMgYW5kIG hlYWx0aGNh cmUgZm9yIH VuZGVyc2Vy dmVkIHBvcH VsYXRpb25z LCByZWR1Y2 luZyB0aGVp ciBlbnZpcm 9ubWVudGFs IGltcGFjdC wgYW5kIHBy b21vdGluZy BkaXZlcnNp dHkgYW5kIG luY2x1c2lv biBpbiB0aG VpciB3b3Jr Zm9yY2UuPG JyPjYuIFN0 cm9uZyBwYX J0bmVyc2hp cHM6IFNhbm 9maSBoYXMg c3Ryb25nIH BhcnRuZXJz aGlwcyB3aX RoIG90aGVy IHBoYXJtYW NldXRpY2Fs IGNvbXBhbm llcywgYWNh ZGVtaWMgaW 5zdGl0dXRp b25zLCBhbm QgaGVhbHRo Y2FyZSBvcm dhbml6YXRp b25zLiBUaG lzIGhlbHBz IHRoZW0gY2 9sbGFib3Jh dGUgb24gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 IGVmZm9ydH MsIGFuZCBi cmluZyBpbm 5vdmF0aXZl IHRyZWF0bW VudHMgdG8g dGhlIG1hcm tldC48YnI+ Ny4gRW1wbG 95ZWUgZGV2 ZWxvcG1lbn Q6IFNhbm9m aSBwcmlvcm l0aXplcyBl bXBsb3llZS BkZXZlbG9w bWVudCBhbm Qgd2VsbC1i ZWluZywgb2 ZmZXJpbmcg YSByYW5nZS BvZiBkZXZl bG9wbWVudC Bwcm9ncmFt cywgZGl2ZX JzaXR5IGFu ZCBpbmNsdX Npb24gaW5p dGlhdGl2ZX MsIGFuZCBi ZW5lZml0cy B0byBzdXBw b3J0IHRoZW lyIGVtcGxv eWVlcy48Yn I+T3ZlcmFs bCwgU2Fub2 ZpIGlzIGEg d2VsbC1lc3 RhYmxpc2hl ZCBhbmQgcm VzcGVjdGVk IHBoYXJtYW NldXRpY2Fs IGNvbXBhbn kgd2l0aCBh IHN0cm9uZy Bmb2N1cyBv biByZXNlYX JjaCwgaW5u b3ZhdGlvbi wgYW5kIHBh dGllbnQtY2 VudHJpYyBh cHByb2FjaG VzIHRvIGlt cHJvdmUgdG hlIGxpdmVz IG9mIHBhdG llbnRzIGFy b3VuZCB0aG Ugd29ybGQu
What the company's business model?
π Want to read more about Sanofi?
Sign up for free
or
log in
βοΈ Sign up to get "The Checklist Value Investor β A Smarter Way to Pick Stocks" for free
U2Fub2ZpIG lzIGEgZ2xv YmFsIGJpb3 BoYXJtYWNl dXRpY2FsIG NvbXBhbnkg dGhhdCBmb2 N1c2VzIG9u IHJlc2Vhcm NoLCBkZXZl bG9wbWVudC wgcHJvZHVj dGlvbiwgYW 5kIG1hcmtl dGluZyBvZi Bpbm5vdmF0 aXZlIGhlYW x0aGNhcmUg c29sdXRpb2 5zLiBJdHMg YnVzaW5lc3 MgbW9kZWwg aXMgY2VudG VyZWQgYXJv dW5kIGZvdX Iga2V5IGFy ZWFzOjxicj 4xLiBSZXNl YXJjaCBhbm QgRGV2ZWxv cG1lbnQ6IF Nhbm9maSBp bnZlc3RzIG hlYXZpbHkg aW4gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50IHRv IGRpc2Nvdm VyIGFuZCBk ZXZlbG9wIG 5ldyBtZWRp Y2luZXMgYW 5kIHZhY2Np bmVzIGZvci B2YXJpb3Vz IGRpc2Vhc2 VzIGFuZCBj b25kaXRpb2 5zLiBUaGlz IGluY2x1ZG VzIGNvbGxh Ym9yYXRpb2 5zIHdpdGgg b3RoZXIgY2 9tcGFuaWVz LCBhY2FkZW 1pYyBpbnN0 aXR1dGlvbn MsIGFuZCBn b3Zlcm5tZW 50cyB0byBh ZHZhbmNlIG l0cyByZXNl YXJjaCBlZm ZvcnRzLjxi cj4yLiBQcm 9kdWN0aW9u IGFuZCBNYW 51ZmFjdHVy aW5nOiBTYW 5vZmkgaGFz IGEgc3Ryb2 5nIHdvcmxk d2lkZSBtYW 51ZmFjdHVy aW5nIGFuZC BzdXBwbHkg Y2hhaW4gbm V0d29yaywg d2l0aCBvdm VyIDQwIHBy b2R1Y3Rpb2 4gc2l0ZXMg aW4gdmFyaW 91cyBjb3Vu dHJpZXMuIF RoaXMgZW5h YmxlcyB0aG UgY29tcGFu eSB0byBlbn N1cmUgYSBz dGVhZHkgc3 VwcGx5IG9m IGl0cyBwcm 9kdWN0cyB0 byBtZWV0IH RoZSBkZW1h bmQgb2YgcG F0aWVudHMg YW5kIGhlYW x0aGNhcmUg cHJvdmlkZX JzLjxicj4z LiBNYXJrZX RpbmcgYW5k IFNhbGVzOi BPbmNlIGEg bmV3IHByb2 R1Y3QgaXMg ZGV2ZWxvcG VkIGFuZCBh cHByb3ZlZC Bmb3IgY29t bWVyY2lhbG l6YXRpb24s IFNhbm9maS B1dGlsaXpl cyB2YXJpb3 VzIG1hcmtl dGluZyBhbm Qgc2FsZXMg c3RyYXRlZ2 llcyB0byBw cm9tb3RlIG FuZCBkaXN0 cmlidXRlIG l0cyBwcm9k dWN0cyBnbG 9iYWxseS4g VGhpcyBpbm NsdWRlcyBw YXJ0bmVyaW 5nIHdpdGgg aGVhbHRoY2 FyZSBwcm92 aWRlcnMsIH BoYXJtYWNp ZXMsIGFuZC BvdGhlciBj b21wYW5pZX MgdG8gcmVh Y2ggYSB3aW RlciBjdXN0 b21lciBiYX NlLjxicj40 LiBEaXZlcn NpZmllZCBQ b3J0Zm9saW 86IFNhbm9m aSdzIGJ1c2 luZXNzIG1v ZGVsIGFsc2 8gaW5jbHVk ZXMgYSBkaX ZlcnNlIHBv cnRmb2xpby BvZiBvdmVy LXRoZS1jb3 VudGVyIChP VEMpIHByb2 R1Y3RzLCBn ZW5lcmljcy wgYW5kIGFu aW1hbCBoZW FsdGggcHJv ZHVjdHMuIF RoaXMgaGVs cHMgdGhlIG NvbXBhbnkg bWl0aWdhdG Ugcmlza3Mg YW5kIGdlbm VyYXRlIHJl dmVudWUgZn JvbSB2YXJp b3VzIHNlZ2 1lbnRzIG9m IHRoZSBoZW FsdGhjYXJl IG1hcmtldC 48YnI+T3Zl cmFsbCwgU2 Fub2ZpJ3Mg YnVzaW5lc3 MgbW9kZWwg aXMgZm9jdX NlZCBvbiBk ZWxpdmVyaW 5nIGlubm92 YXRpdmUgaG VhbHRoY2Fy ZSBzb2x1dG lvbnMgdG8g aW1wcm92ZS B0aGUgbGl2 ZXMgb2YgcG F0aWVudHMg d29ybGR3aW RlLiBJdCBh aW1zIHRvIG FjaGlldmUg bG9uZy10ZX JtIGdyb3d0 aCBhbmQgcH JvZml0YWJp bGl0eSBieS Bjb250aW51 b3VzbHkgaW 52ZXN0aW5n IGluIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCwg ZXhwYW5kaW 5nIGl0cyBw cm9kdWN0IH BvcnRmb2xp bywgYW5kIG 1haW50YWlu aW5nIGEgc3 Ryb25nIGds b2JhbCBwcm VzZW5jZS4=
Is AI a threat?
AI does pose certain material threats to companies like Sanofi, particularly in the pharmaceutical and healthcare sectors. Here are some potential threats related to substitution, disintermediation, and margin pressure:
1. Substitution: AI technologies can potentially lead to the development of new treatments or methods that could substitute for existing Sanofi products. For example, advancements in personalized medicine and AI-driven drug discovery could result in alternative therapeutic options that outperform traditional pharmaceuticals.
2. Disintermediation: AI could enable a more direct connection between patients and healthcare solutions, bypassing traditional pharmaceutical models. For instance, AI-powered telemedicine platforms might offer diagnostic tools and treatment recommendations that reduce the reliance on established pharmaceutical intermediaries, thereby affecting the business dynamics that Sanofi operates within.
3. Margin Pressure: As AI tools become more pervasive in drug development and personalized medicine, the costs associated with bringing new drugs to market could decrease. This increased efficiency might lead to intensified competition, exerting downward pressure on prices and margins for established products. Companies like Sanofi may need to invest more in AI capabilities to maintain a competitive edge, potentially increasing operational costs.
In summary, while AI brings opportunities for innovation and improved healthcare outcomes, it also introduces challenges that could impact Sanofiβs market position and profitability. The company will need to adapt strategically to address these risks effectively.
Sensitivity to interest rates
Sanofiβs earnings, cash flow, and valuation are sensitive to changes in interest rates in several ways:
1. Earnings: Increased interest rates can lead to higher borrowing costs for companies. If Sanofi has variable-rate debt, its interest expenses would rise, potentially reducing net income. Higher rates can also decrease consumer spending, affecting pharmaceutical sales if patients opt for less expensive alternatives or forego treatments.
2. Cash Flow: Cash flow is impacted primarily through financing costs and operational performance. As interest rates rise, Sanofi may face higher costs if refinancing debt or issuing new debt. Additionally, if higher rates lead to economic slowdowns, this can affect overall cash inflows from operations due to decreased sales.
3. Valuation: The present value of future cash flows, which forms the basis of discounted cash flow valuation, is sensitive to the discount rate (often influenced by interest rates). As rates rise, the discount rate increases, potentially lowering the present value of Sanofiβs future cash flows. This can lead to a decrease in stock valuation, as investors may require higher return rates in response to the prevailing interest rate environment.
In summary, while Sanofi operates in a stable industry, increases in interest rates can negatively impact its earnings, cash flows, and overall valuation due to higher costs, reduced consumer spending, and changes in the discount rate applied to future cash flows.
Resilience to the future changes
π Want to read more about Sanofi?
Sign up for free
or
log in
π₯ Free eBook for new users: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
T25lIHJlYW xpc3RpYyBz Y2VuYXJpby B0aGF0IGNv dWxkIHBlcm 1hbmVudGx5 IGltcGFpci BTYW5vZmni gJlzIGVjb2 5vbWljcyBv dmVyIHRoZS BuZXh0IDPi gJM1IHllYX JzIGlzIGEg c2lnbmlmaW NhbnQgYW5k IHByb2xvbm dlZCBmYWls dXJlIGluIH RoZSBkZXZl bG9wbWVudC BvZiBpdHMg cGlwZWxpbm UgZHJ1Z3Ms IHBhcnRpY3 VsYXJseSBp biBoaWdoLX ZhbHVlIHRo ZXJhcGV1dG ljIGFyZWFz IHN1Y2ggYX Mgb25jb2xv Z3ksIGltbX Vub2xvZ3ks IGFuZCBkaW FiZXRlcy4g SWYgU2Fub2 ZpIHdlcmUg dG8gZmFjZS ByZXBlYXRl ZCBjbGluaW NhbCB0cmlh bCBmYWlsdX JlcyBmb3Ig a2V5IGRydW cgY2FuZGlk YXRlcywgZX NwZWNpYWxs eSB0aG9zZS BleHBlY3Rl ZCB0byBkcm l2ZSBmdXR1 cmUgZ3Jvd3 RoLCB0aGUg b3V0Y29tZS Bjb3VsZCBz ZXZlcmVseS BpbXBhY3Qg aXRzIGZpbm FuY2lhbCBo ZWFsdGguPG JyPkluIHRo aXMgc2Nlbm FyaW8sIFNh bm9maeKAmX MgbWFyZ2lu cyB3b3VsZC BsaWtlbHkg ZGVjcmVhc2 UgYXMgdGhl IGNvbXBhbn kgd291bGQg bmVlZCB0by ByZWRpcmVj dCBmdW5kcy Bmcm9tIHBy b2ZpdGFibG UgcHJvZHVj dHMgdG8gY2 9udGludWUg aW52ZXN0aW 5nIGluIHJl c2VhcmNoIG FuZCBkZXZl bG9wbWVudC B3aXRob3V0 IGdlbmVyYX RpbmcgZXhw ZWN0ZWQgcm V0dXJucy4g VGhlIGFic2 VuY2Ugb2Yg bmV3IHByb2 R1Y3RzIGNv dWxkIGxlYW QgdG8gYSBy ZWxpYW5jZS BvbiBleGlz dGluZyBkcn Vncywgd2hp Y2ggbWF5IG ZhY2UgcHJp Y2UgcHJlc3 N1cmVzIGFu ZCBtYXJrZX Qgc2hhcmUg ZXJvc2lvbi BvdmVyIHRp bWUuPGJyPk Nhc2ggZmxv dyB3b3VsZC BhbHNvIGJl IG5lZ2F0aX ZlbHkgYWZm ZWN0ZWQgZH VlIHRvIGxv d2VyIHJldm VudWVzIGZy b20gc2FsZX MuIFRoZSBj b21wYW554o CZcyBvcGVy YXRpb25hbC BjYXNoIGZs b3cgY291bG QgYmVjb21l IGNvbnN0cm FpbmVkLCBs ZWFkaW5nIH RvIGNoYWxs ZW5nZXMgaW 4gZnVuZGlu ZyBvbmdvaW 5nIG9wZXJh dGlvbnMgYW 5kIHJlc2Vh cmNoLiBXaX Rob3V0IG5l dyBwcm9kdW N0cyBjb250 cmlidXRpbm cgdG8gcmV2 ZW51ZSwgU2 Fub2ZpIG1p Z2h0IGFsc2 8gYmUgZm9y Y2VkIHRvIG N1dCBjb3N0 cywgd2hpY2 ggY291bGQg aW5jbHVkZS BsYXlvZmZz IG9yIHJlZH VjdGlvbnMg aW4gbWFya2 V0aW5nIGFu ZCBSJmFtcD tEIHNwZW5k aW5nLiBIb3 dldmVyLCB0 aGVzZSBtZW FzdXJlcyBt YXkgbm90IG JlIHN1ZmZp Y2llbnQgdG 8gb2Zmc2V0 IHRoZSByZX ZlbnVlIHNo b3J0ZmFsbC 48YnI+T24g dGhlIGJhbG FuY2Ugc2hl ZXQsIHRoZS BpbmNyZWFz ZWQgcmVsaW FuY2Ugb24g ZGVidCBjb3 VsZCBiZWNv bWUgZXZpZG VudCBhcyBT YW5vZmkgbW F5IHNlZWsg ZXh0ZXJuYW wgZmluYW5j aW5nIHRvIG 1haW50YWlu IG9wZXJhdG lvbnMgYW5k IGZ1bmQgaX RzIFImYW1w O0QgZWZmb3 J0cyBkdXJp bmcgdGhpcy Bkb3dudHVy bi4gVGhpcy Bjb3VsZCBs ZWFkIHRvIG EgZGVjbGlu ZSBpbiBjcm VkaXQgcmF0 aW5ncyBhbm QgaW5jcmVh c2VkIGJvcn Jvd2luZyBj b3N0cy4gQW RkaXRpb25h bGx5LCBpZi B0aGUgYmFs YW5jZSBzaG VldCByZWZs ZWN0cyBhIG hpZ2hlciBy YXRpbyBvZi BkZWJ0IHRv IGVxdWl0eS wgaXQgY291 bGQgc2lnbm FsIHRvIGlu dmVzdG9ycy Bjb25jZXJu cyBhYm91dC BmaW5hbmNp YWwgc3RhYm lsaXR5Ljxi cj5PdmVyYW xsLCBpZiB0 aGlzIHNjZW 5hcmlvIHdl cmUgdG8gdW 5mb2xkLCBp bnZlc3Rvcn MgY291bGQg cmVhY3Qgbm VnYXRpdmVs eSwgbGVhZG luZyB0byBh IGRlY2xpbm UgaW4gc3Rv Y2sgcHJpY2 VzLCByZWR1 Y2VkIG1hcm tldCBjYXBp dGFsaXphdG lvbiwgYW5k IGEgcG90ZW 50aWFsIGxv c3Mgb2YgY2 9uZmlkZW5j ZSBpbiB0aG UgY29tcGFu eeKAmXMgbG 9uZy10ZXJt IHByb3NwZW N0cy4gT3Zl cmFsbCwgU2 Fub2ZpIHdv dWxkIGZhY2 UgYSBjaGFs bGVuZ2luZy BlY29ub21p YyBlbnZpcm 9ubWVudCB0 aGF0IGNvdW xkIHRha2Ug eWVhcnMgdG 8gcmVjb3Zl ciBmcm9tLC B3aXRoIGxh c3RpbmcgaW 1wbGljYXRp b25zIGZvci BpdHMgZmlu YW5jaWFsIG 1ldHJpY3Mu PGJyPg==
Interesting facts about the company
π Want to read more about Sanofi?
Sign up for free
or
log in
π Free download! "The Checklist Value Investor β A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvWn FnaEQwRDdX NnFURktFSW hFMmMud2Vi cCIgYWx0PS JTYW5vZmki IHRpdGxlPS JTYW5vZmki ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9NTAg d2lkdGg9NT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgU2Fub2Zp PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+agCBE b27igJl0IG 1pc3MgPGk+ IlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3MiPC9pPi DigJQgZnJl ZSEKICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPCEt LQogICAgIC AgICAgICAg ICAgICAgIC AgICA8ZGl2 IHN0eWxlPS dtYXJnaW4t dG9wOiAxMn B4OyBmb250 LXNpemU6ID EzcHg7IGNv bG9yOiAjND Q0Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIG5vdy BhbmQgZ2V0 IG91ciBmcm VlIGVCb29r IAogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGI+VGhlIE NoZWNrbGlz dCBWYWx1ZS BJbnZlc3Rv ciDigJQgQS BTbWFydGVy IFdheSB0by BQaWNrIFN0 b2NrczwvYj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIC0tPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8IS0tCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxkaXYgc3 R5bGU9J21h cmdpbi10b3 A6IDE2cHg7 IGZvbnQtc2 l6ZTogMTRw eDsgY29sb3 I6ICM0NDQ7 IGZvbnQtZm FtaWx5OiAt YXBwbGUtc3 lzdGVtLCBC bGlua01hY1 N5c3RlbUZv bnQsIFNlZ2 9lIFVJLCBS b2JvdG8sIE hlbHZldGlj YSBOZXVlLC BzYW5zLXNl cmlmOyBsaW 5lLWhlaWdo dDogMS42Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BIYXZlIHlv dSBoZWFyZC BhYm91dCBv dXIgc2hvcn QgPHN0cm9u ZyBzdHlsZT 0nZm9udC13 ZWlnaHQ6ID YwMDsnPkRh aWx5IFZpZG VvIE5ld3Ns ZXR0ZXI8L3 N0cm9uZz4/ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICA8 YSBocmVmPS dodHRwczov L3d3dy5pbn NpZ2h0ZnVs dmFsdWUuY2 9tL25ld3Ns ZXR0ZXIucG hwJyB0YXJn ZXQ9J19ibG Fuaycgc3R5 bGU9J2NvbG 9yOiAjMDA3 QkZGOyB0ZX h0LWRlY29y YXRpb246IG 5vbmU7IGZv bnQtd2VpZ2 h0OiA1MDA7 IG1hcmdpbi 1sZWZ0OiA2 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BGaW5kIG91 dCBtb3JlCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 E+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg CiAgICAgIC AgCiAgICAg ICAgPHNwYW 4gY2xhc3M9 J2JsdXJyZW QtdGV4dCc+ CiAgICAgIC AgICAgIFUy RnViMlpwSU cgbHpJR0Vn WjJ4diBZbU ZzSUdobFlX IHgwYUdOaG NtVWcgWTI5 dGNHRnVlUy BCb1pXRmtj WFZoIGNuUm xjbVZrSUcg bHVJRkJoY2 1seiBMQ0JH Y21GdVkyIF VzSUd0dWIz ZHUgSUdadm NpQnBkSCBN Z2QybGtaU0 J5IFlXNW5a U0J2WmkgQn dhR0Z5YldG aiBaWFYwYV dOaGJDIEJ3 Y205a2RXTj AgY3lCaGJt UWdkbSBGal kybHVaWE11 IElFaGxjbV VnWVggSmxJ SE52YldVZy BhVzUwWlhK bGMzIFJwYm 1jZ1ptRmog ZEhNZ1lXSn ZkWCBRZ1Uy RnViMlpwIE 9qeGljajR4 TGkgQklhWE 4wYjNKNSBP aUJUWVc1dl ptIGtnZDJG eklHWnYgY2 0xbFpDQnBi aSBBeU1EQT BJSGRvIFpX NGdkR2hsSU UgWnlaVzVq YUNCdyBhR0 Z5YldGalpY IFYwYVdOaG JDQmogYjIx d1lXNTVJRi BOaGJtOW1h UzFUIGVXNT BhTU9wYkcg RmlieUJ0Wl hKbiBaV1Fn ZDJsMGFDIE JCZG1WdWRH bHogTENCaG JtOTBhRyBW eUlHMWhhbT l5IElIQm9Z WEp0WVcgTm xkWFJwWTJG cyBJR1pwY2 0wdUlGIFJv WlNCeWIyOT AgY3lCdlpp QnBkSCBNZ2 NISmxaR1Zq IFpYTnpiM0 lnWTIgOXRj R0Z1YVdWei BJR05oYmlC aVpTIEIwY2 1GalpXUWcg WW1GamF5Qj BieSBCMGFH VWdaV0Z5IG JIa2dNakIw YUMgQmpaVz UwZFhKNSBM anhpY2o0eU xpIEJIYkc5 aVlXd2cgVU hKbGMyVnVZ MiBVNklGTm hibTltIGFT QnZjR1Z5WV ggUmxjeUJw YmlCdCBiM0 psSUhSb1lX IDRnTVRBd0 lHTnYgZFc1 MGNtbGxjeS BCaGJtUWdh R0Z6IElHRW djMmxuYm0g bG1hV05oYm 5RZyBjSEps YzJWdVkyIF VnYVc0Z1pX MWwgY21kcG JtY2diVyBG eWEyVjBjeX dnIFkyOXVk SEpwWW4gVj BhVzVuSUdF ZyBjM1ZpYz NSaGJuIFJw WVd3Z2NHOX kgZEdsdmJp QnZaaSBCcG RITWdjbVYy IFpXNTFaUz Q4WW4gSStN eTRnVW1Wei BaV0Z5WTJn Z1lXIDVrSU VSbGRtVnMg YjNCdFpXNT BPaSBCVFlX NXZabWtnIG FXNTJaWE4w Y3kgQm9aV0 YyYVd4NSBJ R2x1SUhKbG MyIFZoY21O b0lHRnUgWk NCa1pYWmxi RyA5d2JXVn VkQ3dnIFpt OWpkWE5wYm 0gY2diMjRn WVhKbCBZWE 1nYzNWamFD IEJoY3lCa2 FXRmkgWlhS bGN5d2diMi A1amIyeHZa M2tzIElHbH RiWFZ1YjIg eHZaM2tzSU dGdSBaQ0Iy WVdOamFXID VsY3k0Z1ZH aGwgSUdOdm JYQmhibiBr Z1lXbHRjeU IwIGJ5Qmta WFpsYkcgOX dJR2x1Ym05 MiBZWFJwZG 1VZ2RHIGhs Y21Gd2FXVn ogSUdGdVpD QjBjbSBWaG RHMWxiblJ6 IElIUnZJR0 ZrWkggSmxj M01nZFc1dC BaWFFnYldW a2FXIE5oYk NCdVpXVmsg Y3k0OFluSS tOQyA0Z1Zt RmpZMmx1IF pYTTZJRk5o Ym0gOW1hU0 JwY3lCdiBi bVVnYjJZZ2 RHIGhsSUd4 aGNtZGwgYz NRZ2RtRmpZ MiBsdVpTQn RZVzUxIFpt RmpkSFZ5Wl ggSnpJR2x1 SUhSbyBaU0 IzYjNKc1pD IDRnU1hRZ2 NISnYgWkhW alpYTWdZUy BCaWNtOWha Q0J5IFlXNW 5aU0J2Wmkg QjJZV05qYV c1bCBjeUJt YjNJZ1pHIG x6WldGelpY TWcgYzNWam FDQmhjeSBC cGJtWnNkV1 Z1IGVtRXNJ SEJ2YkcgbH ZMQ0JoYm1R ZyBiV1Z1YV c1bmFYIFJw Y3lCMGFISn YgZFdkb0lH bDBjeSBCem RXSnphV1Jw IFlYSjVMQ0 JUWVcgNXZa bWtnVUdGei BkR1YxY2k0 OFluIEkrTl M0Z1JHbGgg WW1WMFpYTW dRMiBGeVpU b2dVMkZ1IG IyWnBJR2ho Y3kgQmhJSE 4wY205dSBa eUJ3YjNKMF ptIDlzYVc4 Z2FXNGcgWk dsaFltVjBa WCBNZ2JXRn VZV2RsIGJX VnVkQ3dnZD IgbDBhQ0Jo SUhaaCBjbW xsZEhrZ2Iy IFlnYldWa2 FXTmggZEds dmJuTWdZVy A1a0lHMWxa R2xqIFlXd2 daR1YyYVcg TmxjeUJoYV cxbCBaQ0Jo ZENCcGJYIE J5YjNacGJt Y2cgZEdobE lHeHBkbSBW eklHOW1JSE JsIGIzQnNa U0IzYVggUm 9JR1JwWVdK bCBkR1Z6TG p4aWNqIDQy TGlCRGIyMX QgYVhSdFpX NTBJSCBSdk lGTjFjM1Jo IGFXNWhZbW xzYVggUjVP aUJUWVc1di BabWtnYVhN Z1kyIDl0Yl dsMGRHVmsg SUhSdklITj FjMyBSaGFX NWhZbWxzIG FYUjVJR0Z1 WkMgQkRiM0 p3YjNKaCBk R1VnVTI5am FXIEZzSUZK bGMzQnYgYm 5OcFltbHNh WCBSNUlDaE RVMUlwIElH bHVhWFJwWV ggUnBkbVZ6 TENCbSBiMk 4xYzJsdVp5 IEJ2YmlCcG JYQnkgYjNa cGJtY2daMi B4dlltRnNJ R2hsIFlXeD BhQ3dnY20g VmtkV05wYm 1jZyBaVzUy YVhKdmJtID FsYm5SaGJD QnAgYlhCaF kzUXNJRyBG dVpDQndjbT l0IGIzUnBi bWNnWVcgTm paWE56SUhS diBJR2hsWV d4MGFHIE5o Y21VdVBHSn kgUGpjdUlF TlBWayBsRU xURTVJRkps IGMzQnZibk 5sT2kgQkVk WEpwYm1jZy BkR2hsSUVO UFZrIGxFTF RFNUlIQmgg Ym1SbGJXbG pMQyBCVFlX NXZabWtnIF kyOXNiR0Zp YjMgSmhkR1 ZrSUhkcCBk R2dnYjNSb1 pYIElnWTI5 dGNHRnUgYV dWeklHRnVa QyBCdmNtZG hibWw2IFlY UnBiMjV6SU ggUnZJSEpo Y0dsayBiSG tnWkdWMlpX IHh2Y0NCMl lXTmogYVc1 bGN5QmhibS BRZ2RISmxZ WFJ0IFpXNT BjeXdnYUcg bG5hR3hwWj JoMCBhVzVu SUdsMGN5IE JoWjJsc2FY UjUgSUdGdV pDQmpiMiAx dGFYUnRaVz UwIElIUnZJ SEIxWW0geH BZeUJvWldG cyBkR2d1UE dKeVBqIGd1 SUVWdGNHeH YgZVdWbElF SmhjMiBVNk lGUm9aU0Jq IGIyMXdZVz U1SUcgVnRj R3h2ZVhNZy BkR1Z1Y3lC dlppIEIwYU c5MWMyRnUg WkhNZ2IyWW djRyBWdmNH eGxJSGR2IG NteGtkMmxr WlMgd2djbV ZtYkdWaiBk R2x1WnlCcG RIIE1nYzJs NlpTQmggYm 1RZ1pYaDBa VyA1emFYWm xJRzl3IFpY SmhkR2x2Ym 4gTWdhVzRn ZEdobCBJSE JvWVhKdFlX IE5sZFhScF kyRnMgSUds dVpIVnpkSC BKNUxqeGlj ajQ1IExpQl FZWEowYm0g VnljMmhwY0 hNNiBJRk5o Ym05bWFTIE J2Wm5SbGJp QmwgYm1kaF oyVnpJRyBs dUlIQmhjbl J1IFpYSnph R2x3Y3kgQm hibVFnWTI5 cyBiR0ZpYj NKaGRHIGx2 Ym5NZ2QybD AgYUNCdmRH aGxjaSBCdm NtZGhibWw2 IFlYUnBiMj V6TEMgQnBi bU5zZFdScC BibWNnWW1s dmRHIFZqYU NCbWFYSnQg Y3l3Z2RHOG daVyA1b1lX NWpaU0JwIG RITWdjbVZ6 WlcgRnlZMm dnWTJGdyBZ V0pwYkdsMG FXIFZ6SUdG dVpDQmkgY2 1sdVp5QnBi bSA1dmRtRj BhWFpsIElI QnliMlIxWT MgUnpJSFJ2 SUcxaCBjbX RsZEM0OFlu IEkrTVRBdU lFRmogWTJW emN5QjBieS BCTlpXUnBZ Mmx1IFpUb2 dVMkZ1YjIg WnBJR2x6SU dsdSBkbTlz ZG1Wa0lHIG x1SUhaaGNt bHYgZFhNZ2 FXNXBkRyBs aGRHbDJaWE 1nIFlXbHRa V1FnWVggUW dhVzF3Y205 MiBhVzVuSU dGalkyIFZ6 Y3lCMGJ5Qn QgWldScFky RjBhVyA5dW N5QnBiaUJz IGIzZGxjaT FwYm0gTnZi V1VnWTI5MS BiblJ5YVdW eklIIFJvY2 05MVoyZ2cg Wkc5dVlYUn BiMiA1ekxD QndZWEowIG JtVnljMmhw Y0ggTXNJR0 Z1WkNCaCBa bVp2Y21SaF ltIHhsSUhC eWFXTnAgYm 1jZ2MzUnlZ WCBSbFoybG xjeTQ4IFlu SStWR2hsYz IgVWdabUZq ZEhNZyBhV3 hzZFhOMGNt IEYwWlNCVF lXNXYgWm1u aWdKbHpJSC BKdmJHVWdZ WE1nIFlTQn JaWGtnY0cg eGhlV1Z5SU dsdSBJSFJv WlNCbmJHID lpWVd3Z2FH VmggYkhSb1 kyRnlaUyBC c1lXNWtjMk 5oIGNHVWdZ VzVrSUcgbD BjeUJqYjIx dCBhWFJ0Wl c1MElIIFJ2 SUdsdWJtOT IgWVhScGIy NGdZVyA1a0 lIQjFZbXhw IFl5Qm9aV0 ZzZEcgZ3VQ R0p5UGc9PQ ogICAgICAg IDwvc3Bhbj 4KICAgICAg ICAKICAgIC AgICA=
See Company Q&A
π Get full analytics about Sanofi
Sign up for free
or
log in
π Free download! "The Checklist Value Investor β A Smarter Way to Pick Stocks"